Connection

Michael Gold to Arrhythmias, Cardiac

Back to Details
This is a "connection" page, showing publications Michael Gold has written about Arrhythmias, Cardiac.
Michael Gold
Connection Strength
11.282
Arrhythmias, Cardiac
  1. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation. 2021 01 05; 143(1):7-17.
    View in: PubMed
    Score: 0.612
  2. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study. Heart Rhythm. 2020 09; 17(9):1566-1574.
    View in: PubMed
    Score: 0.593
  3. Leadership Letter. Heart Rhythm. 2017 05; 14(5):634.
    View in: PubMed
    Score: 0.481
  4. HRS expands global reach to advance prevention and treatment strategies for arrhythmias. Heart Rhythm. 2016 12; 13(12):2271.
    View in: PubMed
    Score: 0.468
  5. Safety and Efficacy of the Subcutaneous Implantable Defibrillator. J Am Coll Cardiol. 2016 Feb 02; 67(4):445-454.
    View in: PubMed
    Score: 0.442
  6. Are leadless pacemakers a niche or the future of device therapy? J Am Coll Cardiol. 2015 Apr 21; 65(15):1505-8.
    View in: PubMed
    Score: 0.418
  7. A new algorithm to reduce inappropriate therapy in the S-ICD system. J Cardiovasc Electrophysiol. 2015 Apr; 26(4):417-423.
    View in: PubMed
    Score: 0.413
  8. Newer Indications for ICD and CRT. Cardiol Clin. 2014 May; 32(2):181-90.
    View in: PubMed
    Score: 0.386
  9. Subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2012 Jun 01; 5(3):587-93.
    View in: PubMed
    Score: 0.342
  10. Hemoglobin spectroscopy to evaluate hemodynamic function during tachycardias: the future of ICD discrimination algorithms? Heart Rhythm. 2012 Oct; 9(10):1592-3.
    View in: PubMed
    Score: 0.342
  11. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012 Jun 01; 5(3):468-74.
    View in: PubMed
    Score: 0.340
  12. Pre-discharge defibrillation testing: clinically important or obsolete? Europace. 2012 Feb; 14(2):155-6.
    View in: PubMed
    Score: 0.329
  13. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol. 2012 Apr; 23(4):359-66.
    View in: PubMed
    Score: 0.329
  14. Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Curr Opin Cardiol. 2010 May; 25(3):268-75.
    View in: PubMed
    Score: 0.296
  15. Defibrillation threshold testing at implantation: can we predict the patient with a high defibrillation threshold? Europace. 2010 Mar; 12(3):309-10.
    View in: PubMed
    Score: 0.291
  16. The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
    View in: PubMed
    Score: 0.270
  17. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008 Nov 11; 118(20):2022-8.
    View in: PubMed
    Score: 0.267
  18. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007 Jul 15; 100(2):243-6.
    View in: PubMed
    Score: 0.242
  19. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):749-53.
    View in: PubMed
    Score: 0.227
  20. The influence of gender on arrhythmias. Cardiol Rev. 2004 Mar-Apr; 12(2):97-105.
    View in: PubMed
    Score: 0.193
  21. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol. 2004 Feb; 15(2):170-6.
    View in: PubMed
    Score: 0.192
  22. T wave alternans for ventricular arrhythmia risk stratification. Minerva Cardioangiol. 2003 Feb; 51(1):15-9.
    View in: PubMed
    Score: 0.179
  23. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2003 Jan; 18(1):1-5.
    View in: PubMed
    Score: 0.178
  24. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1092-7.
    View in: PubMed
    Score: 0.176
  25. T wave alternans: predictor of arrhythmic events? J Cardiovasc Electrophysiol. 2002 May; 13(5):513-4.
    View in: PubMed
    Score: 0.170
  26. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2002 Jan; 17(1):1-5.
    View in: PubMed
    Score: 0.166
  27. Implantable cardiac defibrillators. Med Clin North Am. 2001 Mar; 85(2):343-67, xi.
    View in: PubMed
    Score: 0.157
  28. Outcomes of two versus three incision techniques: Results from the subcutaneous ICD post-approval study. J Cardiovasc Electrophysiol. 2021 03; 32(3):792-801.
    View in: PubMed
    Score: 0.156
  29. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000 Dec; 36(7):2247-53.
    View in: PubMed
    Score: 0.154
  30. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT. Pacing Clin Electrophysiol. 2000 Nov; 23(11 Pt 2):1981-5.
    View in: PubMed
    Score: 0.153
  31. Permanent His Bundle Pacing Implantation Facilitated by Visualization of the Tricuspid Valve Annulus. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008370.
    View in: PubMed
    Score: 0.152
  32. 1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The?Subcutaneous?ICD?Post?Approval Study. JACC Clin Electrophysiol. 2020 11; 6(12):1537-1550.
    View in: PubMed
    Score: 0.151
  33. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):21-4.
    View in: PubMed
    Score: 0.145
  34. Cardiac arrhythmia: current therapy. Hosp Pract (1995). 1999 Sep 01; 34(9):27-8, 31-2, 35-8 passim.
    View in: PubMed
    Score: 0.141
  35. Optimization of ventricular pacing: where should we implant the leads? J Am Coll Cardiol. 1999 Feb; 33(2):324-6.
    View in: PubMed
    Score: 0.136
  36. The effect of delivered energy on defibrillation shock impedance. J Interv Card Electrophysiol. 1998 Sep; 2(3):273-7.
    View in: PubMed
    Score: 0.132
  37. Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Apr; 9(4):350-4.
    View in: PubMed
    Score: 0.128
  38. Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Mar; 9(3):240-4.
    View in: PubMed
    Score: 0.127
  39. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol. 1997 Jun 15; 79(12):1623-7.
    View in: PubMed
    Score: 0.121
  40. The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure. Am J Cardiol. 2015 Oct 15; 116 Suppl 1:S1-9.
    View in: PubMed
    Score: 0.108
  41. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303.
    View in: PubMed
    Score: 0.098
  42. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. Circ Arrhythm Electrophysiol. 2013 Dec; 6(6):1236-44; discussion 1244-5.
    View in: PubMed
    Score: 0.095
  43. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J. 2011 Oct; 32(20):2516-24.
    View in: PubMed
    Score: 0.081
  44. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011 Jul; 8(7):e1-18.
    View in: PubMed
    Score: 0.080
  45. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011 Jul; 8(7):1114-54.
    View in: PubMed
    Score: 0.080
  46. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Cardiol Clin. 2008 Aug; 26(3):419-31, vi-vii.
    View in: PubMed
    Score: 0.066
  47. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. Congest Heart Fail. 2008 Mar-Apr; 14(2):66-74.
    View in: PubMed
    Score: 0.064
  48. Sport and arrhythmias: summary of an international symposium. Eur J Cardiovasc Prev Rehabil. 2007 Oct; 14(5):707-14.
    View in: PubMed
    Score: 0.062
  49. Distal right ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol. 2003 Oct; 14(10):1036-40.
    View in: PubMed
    Score: 0.047
  50. Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2022 09 27; 80(13):1205-1216.
    View in: PubMed
    Score: 0.044
  51. Pacing for patients with congestive heart failure and dilated cardiomyopathy. Cardiol Clin. 2000 Feb; 18(1):55-66.
    View in: PubMed
    Score: 0.036
  52. A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes. J Interv Card Electrophysiol. 1998 Dec; 2(4):345-9.
    View in: PubMed
    Score: 0.034
  53. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 08 20; 140(8):e382-e482.
    View in: PubMed
    Score: 0.033
  54. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996 Sep 01; 78(5):540-3.
    View in: PubMed
    Score: 0.029
  55. Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol. 1996 Aug 01; 78(3):309-12.
    View in: PubMed
    Score: 0.029
  56. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol. 1996 Aug 01; 78(3):313-6.
    View in: PubMed
    Score: 0.029
  57. Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. Am J Cardiol. 1995 Jun 01; 75(16):1158-61.
    View in: PubMed
    Score: 0.026
  58. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J. 2007 Jun; 153(6):941-50.
    View in: PubMed
    Score: 0.015
  59. Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):219-26.
    View in: PubMed
    Score: 0.012
  60. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000 Jun 29; 342(26):1937-45.
    View in: PubMed
    Score: 0.009
  61. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias. Ann Intern Med. 1992 Mar 01; 116(5):382-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.